Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (131-140 of 460) with videos related to

Pageof 46
Sort By:
Science Signaling|April 3, 2020
4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signalingBenjamin I Philipson, Roddy S O'Connor, Michael J May, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2017
Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T CellsJanos L Tanyi, Caitlin Stashwick, Gabriela Plesa, et al.
Frontiers in Immunology|July 22, 2021
Bispecific Antibody Armed Metabolically Enhanced Headless CAR T CellsArchana Thakur, John Scholler, Ewa Kubicka, et al.
Cell Stem Cell|October 7, 2017
Human Genome Editing in the Clinic: New Challenges in Regulatory Benefit-Risk AssessmentMohamed Abou-El-Enein, Toni Cathomen, Zoltán Ivics, et al.
Blood|January 10, 2002
Adoptive transfer of simian immunodeficiency virus (SIV) naïve autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor statusFrancois Villinger, Gary T Brice, Ann E Mayne, et al.
Cell Reports|September 28, 2017
Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18Biliang Hu, Jiangtao Ren, Yanping Luo, et al.
Journal for Immunotherapy of Cancer|January 22, 2026
CD2 costimulation bridges potent CAR-induced cytolysis and durable persistenceFang Liu, John T Keane, Hyeon S Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapyHua Zhang, Kristen M Snyder, Megan M Suhoski, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|April 30, 2004
Absorbable microparticulate cation exchanger for immunotherapeutic deliveryWaleed S W Shalaby, Heidi Yeh, Edward Woo, et al.
Cancer Immunology Research|August 9, 2014
Nature of tumor control by permanently and transiently modified GD2 chimeric antigen receptor T cells in xenograft models of neuroblastomaNathan Singh, Xiaojun Liu, Jessica Hulitt, et al.
Pageof 46

Showing results (131-140 of 460) with videos related to

Sort By:
Pageof 46
Science Signaling|April 3, 2020
4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signalingBenjamin I Philipson, Roddy S O'Connor, Michael J May, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2017
Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T CellsJanos L Tanyi, Caitlin Stashwick, Gabriela Plesa, et al.
Frontiers in Immunology|July 22, 2021
Bispecific Antibody Armed Metabolically Enhanced Headless CAR T CellsArchana Thakur, John Scholler, Ewa Kubicka, et al.
Cell Stem Cell|October 7, 2017
Human Genome Editing in the Clinic: New Challenges in Regulatory Benefit-Risk AssessmentMohamed Abou-El-Enein, Toni Cathomen, Zoltán Ivics, et al.
Blood|January 10, 2002
Adoptive transfer of simian immunodeficiency virus (SIV) naïve autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor statusFrancois Villinger, Gary T Brice, Ann E Mayne, et al.
Cell Reports|September 28, 2017
Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18Biliang Hu, Jiangtao Ren, Yanping Luo, et al.
Journal for Immunotherapy of Cancer|January 22, 2026
CD2 costimulation bridges potent CAR-induced cytolysis and durable persistenceFang Liu, John T Keane, Hyeon S Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapyHua Zhang, Kristen M Snyder, Megan M Suhoski, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|April 30, 2004
Absorbable microparticulate cation exchanger for immunotherapeutic deliveryWaleed S W Shalaby, Heidi Yeh, Edward Woo, et al.
Cancer Immunology Research|August 9, 2014
Nature of tumor control by permanently and transiently modified GD2 chimeric antigen receptor T cells in xenograft models of neuroblastomaNathan Singh, Xiaojun Liu, Jessica Hulitt, et al.
Pageof 46